|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5567584A
(en)
|
1988-01-22 |
1996-10-22 |
Zymogenetics, Inc. |
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
|
|
US20020099179A1
(en)
|
1989-12-21 |
2002-07-25 |
Linda K. Jolliffe |
Cdr-grafted antibodies
|
|
DK261490D0
(da)
|
1990-10-31 |
1990-10-31 |
Novo Nordisk As |
New pharmaceutical compound
|
|
US6165467A
(en)
|
1991-07-20 |
2000-12-26 |
Yoshihide Hagiwara |
Stabilized human monoclonal antibody preparation
|
|
US5789192A
(en)
|
1992-12-10 |
1998-08-04 |
Schering Corporation |
Mammalian receptors for interleukin-10 (IL-10)
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
JP3681206B2
(ja)
|
1995-12-26 |
2005-08-10 |
株式会社三菱化学ヤトロン |
抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用
|
|
CN1270389C
(zh)
|
1996-06-28 |
2006-08-16 |
精工爱普生株式会社 |
薄膜晶体管及其制造方法
|
|
DE69637856D1
(en)
|
1996-08-30 |
2009-04-16 |
Human Genome Sciences Inc |
Interleukin-19.
|
|
US5985614A
(en)
|
1996-08-30 |
1999-11-16 |
Human Genome Sciences, Inc. |
Polynucleotides encoding interleukin-19
|
|
US5945511A
(en)
|
1997-02-20 |
1999-08-31 |
Zymogenetics, Inc. |
Class II cytokine receptor
|
|
US6323322B1
(en)
|
1997-04-30 |
2001-11-27 |
Enzon, Inc. |
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
|
|
AU8571198A
(en)
|
1997-07-16 |
1999-02-10 |
Human Genome Sciences, Inc. |
Interleukin-20
|
|
US6486301B1
(en)
|
1997-07-16 |
2002-11-26 |
Human Genome Sciences, Inc. |
Interleukin-20
|
|
US6020163A
(en)
|
1997-08-06 |
2000-02-01 |
Zymogenetics, Inc. |
Lipocalin homolog
|
|
US6576743B1
(en)
|
1997-11-26 |
2003-06-10 |
Zymogenetics, Inc. |
Mammalian cytokine-like polypeptide-10
|
|
EP1047781B1
(en)
|
1998-01-23 |
2004-07-28 |
Immunex Corporation |
Il-18 receptors
|
|
WO1999046379A2
(en)
|
1998-03-09 |
1999-09-16 |
Schering Corporation |
Human receptor proteins; related reagents and methods
|
|
ES2312205T3
(es)
|
1998-03-10 |
2009-02-16 |
Genentech, Inc. |
Nuevo polipeptido y acidos nucleicos que lo codifican.
|
|
US7198789B2
(en)
|
1998-03-17 |
2007-04-03 |
Genetics Institute, Llc |
Methods and compositions for modulating interleukin-21 receptor activity
|
|
CN1233476A
(zh)
|
1998-04-24 |
1999-11-03 |
陆道培 |
治疗急性白血病的药物及其制备方法
|
|
WO1999061630A2
(en)
|
1998-05-26 |
1999-12-02 |
Regeneron Pharmaceuticals, Inc. |
Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
|
|
WO1999062934A1
(en)
|
1998-06-05 |
1999-12-09 |
Human Genome Sciences, Inc. |
Interferon receptor hkaef92
|
|
US7071304B2
(en)
|
1998-09-01 |
2006-07-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000015224A1
(en)
|
1998-09-17 |
2000-03-23 |
Eli Lilly And Company |
Protein formulations
|
|
US6451286B1
(en)
*
|
1998-12-21 |
2002-09-17 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
|
|
US7087215B2
(en)
*
|
1998-12-21 |
2006-08-08 |
Generex Pharmaceuticals Incorporated |
Methods of administering and enhancing absorption of pharmaceutical agents
|
|
AU2222700A
(en)
|
1998-12-31 |
2000-07-31 |
Millennium Pharmaceuticals, Inc. |
Class ii cytokine receptor-like proteins and nucleic acids encoding them
|
|
JP2004522402A
(ja)
|
1999-06-02 |
2004-07-29 |
ジェネンテック・インコーポレーテッド |
同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
|
|
US20050060101A1
(en)
|
1999-06-28 |
2005-03-17 |
Bevilacqua Michael P. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
CZ305123B6
(cs)
|
1999-10-04 |
2015-05-13 |
Novartis Vaccines And Diagnostics, Inc. |
Způsob výroby kapalného farmaceutického prostředku
|
|
KR100399156B1
(ko)
*
|
1999-11-19 |
2003-09-26 |
주식회사 엘지생명과학 |
α-인터페론의 용액제형
|
|
RU2279441C2
(ru)
|
1999-12-23 |
2006-07-10 |
Займодженетикс, Инк. |
Выделенный растворимый il-20 рецептор (варианты)
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
EP1272211B1
(en)
|
2000-04-07 |
2007-06-06 |
Signal Coordinating Therapy, Inc. |
Methods and compositions for treating neoplasms
|
|
US7015194B2
(en)
|
2000-05-10 |
2006-03-21 |
Novo Nordisk A/S |
Pharmaceutical composition comprising factor VIIa and anti-TFPI
|
|
AU2001276737A1
(en)
|
2000-08-04 |
2002-02-18 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
AU2001290524A1
(en)
|
2000-08-08 |
2002-02-18 |
Zymogenetics Inc. |
Soluble zcytor 11 cytokine receptors
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
DE60139944D1
(de)
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
|
US7101539B2
(en)
|
2001-02-28 |
2006-09-05 |
Eli Lilly And Company |
Use of LP82 to treat hematopoietic disorders
|
|
JP4009535B2
(ja)
|
2001-03-09 |
2007-11-14 |
ザイモジェネティクス，インコーポレイティド |
可溶性ヘテロダイマーサイトカイン受容体
|
|
ATE454137T1
(de)
|
2001-07-25 |
2010-01-15 |
Facet Biotech Corp |
Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
|
|
EP3254687A1
(en)
|
2001-10-04 |
2017-12-13 |
Genetics Institute LLC |
Methods and compositions for modulating interleukin-21 receptor activity
|
|
US7022289B1
(en)
|
2001-10-10 |
2006-04-04 |
The United States Of America As Represented By The Secretary Of The Army |
Chemical and biological sampling device and kit and method of use thereof
|
|
BRPI0214168B8
(pt)
*
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
WO2003051384A1
(en)
|
2001-12-17 |
2003-06-26 |
Zymogenetics, Inc. |
Method for treating cervical cancer
|
|
WO2003068260A1
(fr)
|
2002-02-14 |
2003-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Produits pharmaceutiques en solution contenant des anticorps
|
|
CA2476934C
(en)
|
2002-02-27 |
2009-06-16 |
Immunex Corporation |
Stabilized tnfr-fc composition comprising arginine
|
|
CA2481304A1
(en)
|
2002-03-27 |
2003-10-09 |
Patrick Hwu |
Method for treating cancer in humans
|
|
US20040009168A1
(en)
*
|
2002-04-05 |
2004-01-15 |
Elizabet Kaisheva |
Multidose antibody formulation
|
|
WO2005123131A2
(en)
|
2004-06-14 |
2005-12-29 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
MXPA04012116A
(es)
|
2002-06-07 |
2005-04-19 |
Zymogenetics Inc |
Uso del il-21 en cancer y otras aplicaciones terapeuticas.
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US20040022792A1
(en)
|
2002-06-17 |
2004-02-05 |
Ralph Klinke |
Method of stabilizing proteins at low pH
|
|
AU2003251592A1
(en)
|
2002-06-21 |
2004-01-06 |
Biogen Idec Inc. |
Buffered formulations for concentrating antibodies and methods of use thereof
|
|
AU2003281528A1
(en)
|
2002-07-18 |
2004-02-09 |
Fabio Perini S.P.A. |
Storage unit for elongated products
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
AU2003293543A1
(en)
*
|
2002-12-13 |
2004-07-09 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
|
CN103040732B
(zh)
|
2003-02-10 |
2015-04-01 |
伊兰药品公司 |
免疫球蛋白制剂及其制备方法
|
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
|
UA97086C2
(uk)
|
2003-07-15 |
2012-01-10 |
Емджен, Інк. |
Виділене людське антитіло, яке специфічно зв'язується з фактором росту нервової тканини (ngf)
|
|
CN100522998C
(zh)
|
2003-10-01 |
2009-08-05 |
协和发酵麒麟株式会社 |
抗体的稳定化方法和被稳定的溶液状抗体制剂
|
|
WO2005063291A1
(ja)
|
2003-12-25 |
2005-07-14 |
Kirin Beer Kabushiki Kaisha |
抗体を含有する安定な水性医薬製剤
|
|
EA015706B1
(ru)
|
2004-10-22 |
2011-10-31 |
Займоджинетикс, Инк. |
Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
|
|
WO2006086396A2
(en)
|
2005-02-08 |
2006-08-17 |
Zymogenetics, Inc. |
Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
|
|
US7525604B2
(en)
|
2005-03-15 |
2009-04-28 |
Naxellent, Llc |
Windows with electrically controllable transmission and reflection
|
|
EP2264162A1
(en)
|
2005-07-02 |
2010-12-22 |
Arecor Limited |
Stable aqueous systems comprising proteins
|
|
WO2007006858A2
(en)
|
2005-07-12 |
2007-01-18 |
Oy Jurilab Ltd |
Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
|
|
CA2618068C
(en)
|
2005-08-05 |
2016-02-16 |
Amgen Inc. |
Stable aqueous protein or antibody pharmaceutical formulations and their preparation
|
|
WO2007038501A2
(en)
|
2005-09-27 |
2007-04-05 |
The Feinstein Institute For Medical Research |
Rheumatoid arthritis markers
|
|
EP2161348A1
(en)
|
2005-09-27 |
2010-03-10 |
Source MDX |
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
|
|
KR101357685B1
(ko)
|
2005-11-21 |
2014-02-06 |
사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 |
재조합 바이러스용 안정화 제형
|
|
JP5405122B2
(ja)
|
2005-12-21 |
2014-02-05 |
ワイス・エルエルシー |
低粘度のタンパク質製剤およびその用途
|
|
JP5231810B2
(ja)
|
2005-12-28 |
2013-07-10 |
中外製薬株式会社 |
抗体含有安定化製剤
|
|
JP2009525986A
(ja)
|
2006-02-03 |
2009-07-16 |
メディミューン，エルエルシー |
タンパク質製剤
|
|
DE102006005094A1
(de)
|
2006-02-04 |
2007-08-09 |
Degussa Gmbh |
Titandioxid und Polycarboxylatether enthaltende Dispersion
|
|
TW200744634A
(en)
|
2006-02-21 |
2007-12-16 |
Wyeth Corp |
Methods of using antibodies against human IL-22
|
|
JP2009530699A
(ja)
|
2006-03-15 |
2009-08-27 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
ロール検出を備えたリモートコントロール型ポインティング技術
|
|
TW200806317A
(en)
|
2006-03-20 |
2008-02-01 |
Wyeth Corp |
Methods for reducing protein aggregation
|
|
EP2006380A4
(en)
|
2006-03-23 |
2010-08-11 |
Kyowa Hakko Kirin Co Ltd |
AGONIST ANTIBODY AGAINST THE HUMAN THROMBOPOIETINE RECEPTOR
|
|
CA2647111A1
(en)
*
|
2006-03-28 |
2007-10-04 |
F. Hoffmann-La Roche Ag |
Anti-igf-1r human monoclonal antibody formulation
|
|
EP1857559A1
(en)
|
2006-05-16 |
2007-11-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A method for predicting responsiveness to TNF alpha blocking agents
|
|
JP2009540015A
(ja)
|
2006-06-14 |
2009-11-19 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
抗ｅｇｆｒ抗体の凍結乾燥製剤
|
|
CN101472611A
(zh)
|
2006-06-19 |
2009-07-01 |
惠氏公司 |
调节il-22和il-17的方法
|
|
DK2038306T3
(en)
|
2006-06-30 |
2015-03-09 |
Novo Nordisk As |
ANTI-NKG2A ANTIBODIES AND APPLICATIONS THEREOF
|
|
CA2665567C
(en)
|
2006-10-06 |
2012-07-03 |
Amgen Inc. |
Stable formulations
|
|
KR20090069330A
(ko)
|
2006-10-12 |
2009-06-30 |
와이어쓰 |
유백광/응집체를 감소시키기 위한 항체 용액 중의 이온 강도의 변화
|
|
US20100267575A1
(en)
|
2006-10-17 |
2010-10-21 |
Childrens Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
|
CA2668955A1
(en)
|
2006-11-09 |
2008-05-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method for predicting therapeutic responsiveness to tnf-alpha blocking agents
|
|
CN101553504A
(zh)
|
2006-12-11 |
2009-10-07 |
豪夫迈·罗氏有限公司 |
Aβ抗体胃肠外制剂
|
|
WO2009077483A1
(en)
|
2007-12-14 |
2009-06-25 |
Novo Nordisk A/S |
Antibodies against human nkg2d and uses thereof
|
|
JP5419709B2
(ja)
*
|
2007-01-09 |
2014-02-19 |
ワイス・エルエルシー |
抗ｉｌ−１３抗体製剤およびその使用
|
|
US20100273671A1
(en)
|
2007-03-01 |
2010-10-28 |
Universite Catholique De Louvain |
Method for the determination and the classification of rheumatic conditions
|
|
KR101087344B1
(ko)
|
2007-03-23 |
2011-11-25 |
파나소닉 주식회사 |
도전성 범프와 그 제조 방법 및 전자 부품 실장 구조체
|
|
KR101540823B1
(ko)
|
2007-03-30 |
2015-07-30 |
메디뮨 엘엘씨 |
항체 제제
|
|
GB0707938D0
(en)
|
2007-04-25 |
2007-05-30 |
Univ Strathclyde |
Precipitation stabilising compositions
|
|
WO2008132176A2
(en)
|
2007-04-27 |
2008-11-06 |
Universite Catholique De Louvain |
Method for evaluating the response of an individual to tnf blocking therapy
|
|
SG182183A1
(en)
|
2007-06-08 |
2012-07-30 |
Biogen Idec Inc |
Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
|
|
US20090208492A1
(en)
|
2007-06-14 |
2009-08-20 |
Elan Pharmaceuticals, Inc. |
Lyophilized Immunoglobulin Formulations and Methods of Preparation
|
|
CA2690382A1
(en)
|
2007-06-14 |
2008-12-24 |
Biogen Idec Ma Inc. |
Antibody formulations
|
|
US20090004189A1
(en)
|
2007-06-18 |
2009-01-01 |
Genentech, Inc. |
Biological markers predictive of rheumatoid arthritis response to b-cell antagonists
|
|
AU2008269086B2
(en)
|
2007-06-25 |
2014-06-12 |
Amgen Inc. |
Compositions of specific binding agents to hepatocyte growth factor
|
|
US20100189721A1
(en)
|
2007-07-06 |
2010-07-29 |
Smithkline Beecham Corporation |
Antibody formulations
|
|
UA107557C2
(xx)
|
2007-07-06 |
2015-01-26 |
|
Композиція антитіла офатумумабу
|
|
EP2174132A2
(en)
|
2007-07-20 |
2010-04-14 |
National Institute for Bioprocessing Research and Training Limited |
Glycosylation markers for cancer and chronic inflammation
|
|
US20100261613A1
(en)
|
2007-07-26 |
2010-10-14 |
Michael Centola |
Methods for inflammatory disease management
|
|
EP2225275A4
(en)
|
2007-11-28 |
2013-04-03 |
Medimmune Llc |
PROTEIN FORMULATION
|
|
CA2714296A1
(en)
|
2008-02-20 |
2009-08-27 |
G2 Inflammation Pty Ltd |
Humanized anti-c5ar antibodies
|
|
WO2009120684A1
(en)
|
2008-03-25 |
2009-10-01 |
Medimmune, Llc |
Antibody formulation
|
|
CN103396480A
(zh)
|
2008-05-15 |
2013-11-20 |
诺沃—诺迪斯克有限公司 |
抗体纯化方法
|
|
TWI451876B
(zh)
*
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
KR20110039218A
(ko)
|
2008-06-30 |
2011-04-15 |
노보 노르디스크 에이/에스 |
항－인간 인터루킨－２０ 항체
|
|
UA112050C2
(uk)
*
|
2008-08-04 |
2016-07-25 |
БАЄР ХЕЛСКЕР ЛЛСі |
Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
|
|
KR20110048536A
(ko)
|
2008-08-28 |
2011-05-11 |
와이어쓰 엘엘씨 |
자가면역 질병에서 ｉｌ－２２, ｉｌ－１７ 및 ｉｌ－１ 패밀리 시토킨의 용도
|
|
PE20110302A1
(es)
|
2008-09-19 |
2011-05-21 |
Hoffmann La Roche |
Formulacion farmaceutica de un anticuerpo contra p-selectina
|
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
WO2010072691A1
(en)
|
2008-12-22 |
2010-07-01 |
Novo Nordisk A/S |
Antibodies against tissue factor pathway inhibitor
|
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
|
JP5996429B2
(ja)
|
2009-09-03 |
2016-09-21 |
ジェネンテック， インコーポレイテッド |
関節リウマチの治療、診断及びモニターするための方法
|
|
US8580528B2
(en)
|
2009-10-16 |
2013-11-12 |
Stichting Vu-Vumc |
Method for prognosticating the clinical response of a patient to B-lymphocyte inhibiting or depleting therapy
|
|
US20120208719A1
(en)
|
2009-10-16 |
2012-08-16 |
Mayo Foundation For Medical Education And Research |
Assessing rheumatoid arthritis
|
|
SI3409289T1
(sl)
|
2010-02-26 |
2020-12-31 |
Novo Nordisk A/S |
Stabilni sestavki, ki vsebujejo protitelo
|
|
RU2012153786A
(ru)
|
2010-05-28 |
2014-07-10 |
Ново Нордиск А/С |
Стабильные многодозовые композиции, содержащие антитело и консервант
|
|
WO2011154139A2
(en)
|
2010-06-07 |
2011-12-15 |
Roche Diagnostics Gmbh |
Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|